Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although software-as-a-service business Salesforce.com ...

Vivoryon Therapeutics N.V. Annual stock financials by MarketWatch. View the latest VVY financial statements, income statements and financial ratios.

If you're interested in Vivoryon Therapeutics AG (AMS:VVY), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your ...

The average one-year price target for Vivoryon Therapeutics N.V. (AMS:VVY) has been revised to 55.59 / share. This is an increase of 11.22% from the prior estimate of 49.98 dated August 1, 2023. The ...

Trailing total returns as of 2026-06-12, which may include dividends or other distributions. Benchmark is AEX-Index (^AEX) ...

At close: 2 April at 5:35:00 pm GMT+2 ...

At close: 5 December at 17:35:20 CET ...

Find the latest Vivoryon Therapeutics N.V. (VVY.AS) stock quote, history, news and other vital information to help you with your stock trading and investing.

About Vivoryon Therapeutics N.V. Vivoryon Therapeutics NV is a biopharmaceutical company, which engages in the research and development of therapeutic products for the treatment of Alzheimer's disease ...

As of 10:38:28 am GMT+2. Market open.

At close: 5:23:38 pm GMT+1 ...